Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
R Don Elsey is Director at Bullfrog AI Holdings. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 15, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
Jun 11, 202615Kdisclosed Jun 15
DetailsOfficial recordR Don Elsey bought shares on the open market in 2006, and has not bought since 2006. Sales in 3 of the 21 years since 2006.
R Don Elsey reported 1 open-market purchase and 83 sales since 2006; purchases in 2006.
| Year | Bought | Sold |
|---|---|---|
| 2011 | — | $360K1×1 trade |
| 2009 | — | $276K62×62 trades |
| 2008 | — | $1.16M20×20 trades |
| 2006 | $3.4K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
R Don Elsey bought shares on the open market in 2006, and has not bought since 2006. Sales in 3 of the 21 years since 2006.
In SEC filings since 2006: the latest open-market purchase is from 2006; the latest open-market sale is from 2011.
Emergent Biosolutions (EBS), from 2006 to 2011: 1 purchase and 83 sales.
R Don Elsey reported 1 open-market purchase and 83 sales here, 2006 to 2011.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
